50-155-7218

EMSY Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-7218-Each-of-1 In Stock ₹ 12,384.35

50-155-7218 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

EMSY

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

Q7Z589, Q8BMB0

Gene Symbols

EMSY

Immunogen

Between 1250 and C-term

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Applications

Immunohistochemistry, Western Blot

Conjugate

Unconjugated

Gene

EMSY

Gene Alias

C11orf30, chromosome 11 open reading frame 30, EMSY BRCA2-interacting transcriptional repressor, EMSY, BRCA2-interacting transcriptional repressor, GL002, protein EMSY

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

233545, 56946

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-155-7216

--

Img

Bethyl Laboratories, Inc

50-155-7426

--

Img

Bethyl Laboratories, Inc

50-155-7261

--

Img

Bethyl Laboratories, Inc

50-155-7247

--

Img

Bethyl Laboratories, Inc

50-155-7252

--

Img

Bethyl Laboratories, Inc

50-155-7699

--

Img

Bethyl Laboratories, Inc

50-155-7348

--

Img

Bethyl Laboratories, Inc

50-155-7897

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Application Note: For IHC, epitope retrieval with Tris-EDTA pH 9.0 is recommended for FFPE tissue sections
  • EMSY is a regulator which is able to repress transcription, possibly via its interaction with a multiprotein chromatin remodeling complex that modifies the chromatin
  • Its interaction with BRCA2 suggests that it may play a central role in the DNA repair function of BRCA2
  • As part of a histone H3-specific methyltransferase complex may mediate ligand-dependent transcriptional activation by nuclear hormone receptors
  • Diseases associated with EMSY include Sporadic Breast Cancer and Breast Cancer.